N-bromobutanimide → HCID 59333304, compound
Reaction equation
[Cl:1][C:2]1[C:3]2[N:4]([CH:17]=[CH:18][N:19]=2)[C:5]2[C:10]([N:11]=1)=[CH:9][C:8]([O:12][C:13]([F:16])([F:15])[F:14])=[CH:7][CH:6]=2.[Br:20]N1C(=O)CCC1=O>ClCCl>[Br:20][C:17]1[N:4]2[C:5]3[C:10]([N:11]=[C:2]([Cl:1])[C:3]2=[N:19][CH:18]=1)=[CH:9][C:8]([O:12][C:13]([F:14])([F:15])[F:16])=[CH:7][CH:6]=3Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 30 °C
Procedure
To a stirred solution of 4-chloro-7-(trifluoromethoxy)imidazo[1,2-a]quinoxaline (5.4 g, 18.8 mmol, 1 eq) prepared as described in example 7 step 4 in dichloromethane (94 mL) is added N-bromosuccinimide (5.0 g; 28.2 mmol; 1.5 eq). The solution becomes green during the addition. The solution is allowed to stir for 7 hours at 30° C. until completion of the reaction. Then, the solution is concentrated under vacuum and purified by chromatography on a silica gel column (chloroform/cyclohexane 7:3) to afford the title compound still contaminated by 10% of residual N-bromosuccinimide (7.2 g; 17.7 mmol; 94%). The compound is used as such in the next step without further purification.
Workup
- additionThe solution becomes green during the addition
- concentrationThen, the solution is concentrated under vacuum
- custompurified by chromatography on a silica gel column (chloroform/cyclohexane 7:3)
Sources & evidence
- ORD record
- ord-c8d2f511c5f64d0ba2b5f91592e61055
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08513250B2
Reaction notes
Loading…